Brief: HLS Therapeutics Announces Q2 2026 Financial Results
12/08/2026 13:16
BRIEF-HLS Therapeutics Announces Q2 2026 Financial Results Aug 12 (Reuters) - HLS Therapeutics Inc HLS.TO:
HLS THERAPEUTICS ANNOUNCES Q2 2026 FINANCIAL RESULTS
HLS THERAPEUTICS INC: REAFFIRMS ITS 2026 FINANCIAL TARGETS
Source text: ID:nCNWnBjj6a
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group